IV Products
nPulse needlefree device has been cleared by the U. S. Food and Drug Administration for marketing in the United States
Intravenous products: NP Medical reports “NP Medical (www.npmedical.com) has released a new, patented, needle-free access device intended to help
…
FDA 510(k) market clearance: ARROW VPS Device with micro-Doppler ultrasound technology in combination with intravascular ECG
Intravenous products: Businesswire report “Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for critical care and surgery, announces that its
Piperacillin and Tazobactam precipitation or crystallization in IV bag or IV line upon reconstitution
Intravenous products: FDA report “Apotex Corp. notified healthcare professionals it is conducting, on behalf of the manufacturer Hospira, Inc., a
GemStar Infusion System FDA class 1 recall due to lithium battery low voltage problem
Intravenous products: FDA report “Hospira notified healthcare professionals of a Class I recall of the GemStar Infusion System, Models 13000, 13100,
Ready to administer Metoclopramide Injection: The FDA have approved a second BD Simplist product
Intravenous products: News Medical report “BD Rx Inc., a wholly-owned subsidiary of leading global medical technology company BD (Becton, Dickinson and Company) (NYSE:
FDA report recall of sodium chloride injection 0.9 percent by Hospira: Recall due to particulate matter
Intravenous products: The FDA report “Hospira notified the public that last August it initiated a voluntary nationwide user-level recall of one lot of 0.9% Sodium
The BD UltraSafe PLUS™ Passive Needle Guard has received 510(k) clearance as an anti-needlestick safety device
Intravenous products: BD report “BD Medical, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company,
Animas Corporation 2020 Insulin Infusion Pump: Class I Recall – False alarm or warning sound
Intravenous products: FDA report “Animas identified a component issue affecting Animas 2020 Infusion Insulin Pumps manufactured from March 1, 2012 to
Sodium Chloride Injection, 0.9 percent, 1000 mL, flexible container: Recall due to brass particulates
Intravenous products: FDA report “Hospira, Inc. notified healthcare professional of a voluntary nationwide user-level recall of one lot of 0.9% Sodium Chloride
Real-time visualization and time-savings tool for ultrasound-guided procedures now available on select SonoSite Ultrasound System
Intravenous products: Business wire report “FUJIFILM SonoSite, Inc., the world leader and pioneering specialist in bedside and point-of-care ultrasound, today
